Future Industry Innovation Development Forum

Address: Changchun Hall Time: 05/ 27 09:00 ~ 12:10

9:00-9:10	Leaders' Remarks
9:10-9:20	Signing Ceremony and Results Release
9:10-9:15	Signing Ceremony on Synergetic Development of Urban Areas
9:15-9:20	Release of GCT Alliance, Supporting Projects and Technology Ranking
9:20-11:20	Keynote Speeches
9:20-9:35	< New Insight into China Drug Evaluation and Approval> Tao Wang, Deputy Director of the Center for Drug Evaluation, NMPA
9:35-9:50	<Policy and Latest Regulatory Trends in CAR-T Cell Therapy> Peter Marks, M.D., Ph.D., Director of Center for Biologics Evaluation and Research, FDA
9:50-10:05	<Clinical Update and Prospect of CAR-T Cell Therapy> Ning Li, Vice President of National Canter Center/Cancer Hospital, Chinese Academy of Medical Sciences
10:05-10:20	< Engineering Human Pluripotent Stem Cells to Produce Immune Cells with Improved Anti-Tumor Activity > Dan Kaufman, M.D., Ph.D., Professor of Medicine, Director of Cell Therapy Program UC San Diego Moores Cancer Center
10:20-10:35	<Thermo Fisher accelerates the process of CGT innovation and commercialization in China> Hann Pang, President of Thermo Fisher Scientific China
10:35-10:50	<Performance Enhancement of Immunity: Pushing the Design Envelope in T Cell Manufacturing> Bruce Levine, Ph.D., Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine
10:50-11:05	<Capital Markets Fuel the Future of GCT> Yuan Gao, Managing Director of Huatai United Securities
11:05-11:20	<Innate Immunity: New Developments in an Ancient Field> Jules Hoffmann, Ph.D., Chair of Integrative Biology, University of Strasbourg Institute for Advanced Study (USIAS)，2011 Nobel Laureate in Physiology or Medicine
11:20-12:10	High-level Dialogue: From Technological Innovation to Commercialization, Unfold the Next Decade for Cell Therapy
	Moderator：Richard Wang, Ph.D., Chairman & CEO, Neukio Biotherapeutics
	Panelists: 1.Nannan Chang Ph.D., Executive Director, GL Ventures 2.Jie Ma, Professor, Director of Biotherapy Center, Beijing Hospital 3.Lin Yang, Ph.D., Founder & Chairman, PersonGen BioTherapeutics 4.Xueqiang Zhao, Ph.D., Co-founder, BriSTAR Immunotech 5.Ting He, Ph.D., Founder & CEO, IMUNOPHARM

*The final agenda is subject to the actual